
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cephalo Ventures is a venture capital organization founded to support scientific research and innovation. Established with a mission to invest in scientific advancements, the firm operates in both the United States and the United Kingdom. Cephalo Ventures focuses on sectors that have the potential to positively impact society, particularly in therapeutics, synthetic biology, and medical devices.
Currently, Cephalo Ventures manages a portfolio of four notable companies and offers a fundraising-focused accelerator program called Transferase Accelerator. This program is designed to provide startups with workshops and access to a network of biotech investors. The firm emphasizes investments that yield significant societal impact through scientific advancements.
Cephalo Ventures specializes in early-stage biotech startups, targeting companies in the pre-seed to Series A funding stages. The firm provides funding ranging from $150,000 to $300,000, making it an attractive option for startups seeking initial capital. Their investment strategy is centered on scientific advancements in therapeutics, synthetic biology, and medical devices, aiming to support innovations that can lead to substantial societal benefits.
The organization also runs the Transferase Accelerator, which is designed to assist startups in their fundraising efforts. This program includes workshops that equip founders with essential skills and knowledge, as well as access to a network of experienced biotech investors. Cephalo Ventures looks for startups that demonstrate potential for significant impact and innovation in their respective fields.
Cephalo Ventures has invested in four notable companies within the biotech sector:
These companies reflect Cephalo Ventures' commitment to supporting scientific advancements that have the potential to create a positive societal impact.
Startups interested in pitching to Cephalo Ventures should visit their website for application details. A well-structured pitch deck should include information on the team, market opportunity, and the technology or product being developed. Response times may vary, so founders are encouraged to follow up if they do not receive timely feedback.
Cephalo Ventures runs the Transferase Accelerator, a fundraising-focused program designed to support early-stage biotech startups. This program includes workshops that provide essential skills for fundraising and access to a network of biotech investors. Startups interested in participating can apply through the Cephalo Ventures website.
What are Cephalo Ventures' investment criteria?
Cephalo Ventures invests in early-stage biotech startups, specifically those in the pre-seed to Series A funding stages. The firm focuses on companies that demonstrate potential for significant societal impact through scientific advancements in therapeutics, synthetic biology, and medical devices.
How can startups apply or pitch to Cephalo Ventures?
Interested startups can apply or pitch by visiting the Cephalo Ventures website. The site provides information on the application process and guidelines for submissions.
What makes Cephalo Ventures different from other venture capital firms?
Cephalo Ventures distinguishes itself by focusing exclusively on biotech innovations that have the potential for societal impact. Their commitment to scientific advancements and the support provided through the Transferase Accelerator program sets them apart.
What is the geographic scope of Cephalo Ventures?
The firm operates primarily in the United States and the United Kingdom, targeting biotech startups in these regions.
What is the typical check size for investments?
Cephalo Ventures typically invests between $150,000 and $300,000 in early-stage biotech startups.
What kind of post-investment involvement does Cephalo Ventures have?
Cephalo Ventures provides support through its Transferase Accelerator program, which includes workshops and access to a network of biotech investors, helping startups navigate their growth and fundraising efforts.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.